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Lactoferrin mRNA in the 21-day-old mouse uterus can be increased several hundredfold by estrogen. The physiological role of lactoferrin in mouse
uterus is unclear; however, it can be a useful marker for the estrogen action in the uterus. The structural organization and the chromosome location
of the lactoferrin gene are similar to members of the transferrin gene family. At the 5' flanking region of the lactoferrin gene, we have characterized
two modules that respond to estrogen and growth factor stimulation. Each module is composed of either overlapping or multiple transcription
factor-binding elements. The well-characterized estrogen and growth factor response modules in the mouse lactoferrin gene could serve as the
foundation to understand the intricate molecular mechanisms of estrogen action and its relationship to growth factors. - Environ Health Perspect
103(Suppl 7):17-20 (1995)
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Introduction
Lactoferrin, an iron-binding glycoprotein,
was originally found in milk 55 years ago
(1). It was also present in neutrophilic
leukocytes, saliva, tears, seminal plasma,
uterine fluid, vaginal fluid, and wet surface
mucosa (2-4). Lactoferrin, together with
transferrin and melanoma antigen p97,
belongs to a gene family that arose from
ancient intragenic duplication 300 to 500
million years ago (5-7). The lactoferrin
gene was mapped to human chromosome
3 and mouse chromosome 9 (8). Deduced
mouse lactoferrin from the cDNA clone
(9) exhibits internal homologies between
N-terminal and C-terminal domains simi-
lar to those of the human lactoferrin pro-
tein (10,11). Like transferrin, lactoferrin
has two metal-binding sites, each ofwhich
can bind a ferric (Fe3+) cation and a
bicarbonate anion (10).
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Lactoferrin protein has been reported
to have multiple functions. It has a broad
spectrum of antimicrobial properties
(12-15); other functions, such as promot-
ing DNA synthesis (16), modulating the
immune system (17-23) and inhibiting
tumor growth (24) have also been
reported. The wide variety of biological
functions highlights the importance of the
regulation of this gene in individual tissue
and cell types. Although many studies have
been done on the distribution of the pro-
tein, relatively little is understood about
the molecular mechanisms that regulate its
expression. In the 10 years that our labora-
tory has been studying regulation of the
lactoferrin gene in the mouse uterus, we
have found that the gene is a sensitive
marker for estrogen in the mouse uterus
(9,25). Therefore, the expression of the
lactoferrin gene in mouse uterus could be a
parameter for detecting estrogenic chemi-
cals in the environment. In this review, I
will discuss the organization of the gene,
the characterization of the estrogen and
epidermal growth factor (EGF) response
elements, and the gene's potential use in
environmental study.
Organization ofthe Mouse
Lactoferrin Gene
The mouse lactoferrin gene is organized
into 17 exons interrupted by 16 introns.
The size ofthe exons matches other mem-
bers of the transferrin gene family and is
conserved during evolution (26,27). There
is strong homology between the pairs of
exons and the splicing pattern (Tables
1 and 2), which explains the internal
homology that exists between N- and
C-terminal domains of the protein. These
results strongly support the hypothesis that
the transferrin gene family is originated by
a duplication of a common ancestral gene
half the size of transferrin (5-7). The
Table 1. Internal homologies of the mouse lactoferrin
gene.
Exon Exon size, nt Amino acid interruption
2 161 No
9 155 No
3 109 C/AG Glutamine
10 91 A/M Lysine
4 183 G/CG Alanine
12 156 A/AT Asparagine
5 148 AG/G Arginine
13 142 AG/G Arginine
6 56 G/AG Glutamic acid
14 68 G/GG Glycine
7 179 No
15 185 No
8 175 A/AG Lysine
16 190 C/CA Proline
nt, nucleotide. Compare the exon size of the 5' and 3'
half ofthe gene.
Table 2. Identical splicing pattern ofthe corresponding
exons in the mouse lactoferrin gene.
Exons Splicing pattern
1, (3,110)a(4,12) (6,14) (8,16), 11 Xb[GTAGC] yZb
(5,13) Xyb[GTAGCI zb
(2,9) (7,15) XyZb[GTAGcI
aThe homologous exons are in parentheses. bThe
nucleotides of the last and first codons of the adjacent
exons. cThe intron interrupting the coding sequence
XYZ starts with GTand ends with AG.
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gene family, which contributes to the
varying sizes of the genes. The mouse
lactoferrin gene is encoded by a single copy
gene of30 kilobases (kbp) that includes the
7.5 kbp promoter/enhancer and 23 kbp of
the gene (27-29).
Estrogen Regulation ofthe
LactofenTin Gene
The expression of the lactoferrin gene in
mouse uterus is especially sensitive to estro-
gen (4,9,25). Four hours after a 21-day-old
mouse was injected with estrogen, the level
of lactoferrin messenger RNA (mRNA)
increased (Figure 1); with three injections,
the level reached up to 300-fold (9). Fur-
thermore, lactoferrin protein and mRNA in
the uterus and the estrogen levels in the
plasma fluctuate during the estrous cycle of
a mouse (30). At diestrus the lactoferrin
mRNA was low and immunostaining ofthe
lactoferrin in uterine epithelial cells was
weak. There was no detectable lactoferrin
DES
mLF
H2B
- 4hr 8hr 3days
2.4 kbp
0.3 kbp
in the uterine fluid. At proestrus, the
mRNA and protein increased and the lacto-
ferrin was readily detectable in the uterine
fluid. Both lactoferrin mRNA and protein
reached the highest level at estrus and then
decreased as the cycle entered metestrus.
Fluctuation of lactoferrin and its mRNA
was the result of both production and the
number of cells that were involved.
Oviductal and vaginal epithelial cells also
produce lactoferrin under the influence of
estrogen; however, production was not as
dramatic as in the uterus. There was no evi-
dence that the lactoferrin gene was regu-
lated by estrogen in other tissues or cells
other than the female reproductive tract.
The Estrogen Response
Module
Analyzing the 5' flanking region of the
lactoferrin gene, we found an imperfect
estrogen response element (ERE) that over-
lapped with a chicken ovalbumin upstream
promoter (COUP) (28,31). This compos-
ite estrogen response module (mERM) was
located at position -349 to -329 from the
transcription initiation site. The ERE ele-
ment differed from the consensus ERE
sequence (32) by one nucleotide at the sec-
ond position of the 3' half of the element
(G to A); the COUP element differed by
one nucleotide from the chicken COUP
element (33). The ERE element and COUP
element, either alone or together (mERM),
were cloned in a reporter CAT plasmid
and then transiently transfected into
Reporter constructs
CAT
psv-CATO
psv-mCAT5
psv-mCAT6
CAT
psv-mCAT7_
---1. -CAT
psv-mCAT7
psv-mC 9 _CAT psv-mCAT9 -- ~ ~
human endometrium carcinoma RL95-2
cells to assess hormone responsiveness. We
found that the ERE element conferred
estrogen action to both homologous and
heterologous promoters (Figure 2)(30).
Results ofthe electromobility shift assay
(EMSA) showed that the estrogen receptor
and COUP transcription factor (COUP-
TF) were present in mouse uterine tissue
and interacted with the COUP/ERE ele-
ment specifically. In addition, specific anti-
bodies to the estrogen receptor and the
COUP-TF could correspondingly super-
shift the band. The unusual organization of
the ERE in the mouse lactoferrin gene pro-
vided an opportunity to study the func-
tional relationship between the two
members of the steroid hormone receptor
superfamily. Mutation and deletion of the
COUP element or reduction of the
endogenous COUP-TF increased mERM
estrogen responsiveness. Likewise, overex-
pression of the COUP-TF expression vec-
tor blocked the estrogen-stimulated
response of mERM in transfected cells.
The molecular mechanism of this repres-
sion is due to the competition between
COUP-TF and estrogen receptor to bind
at identical contact sites in the overlapping
region ofthe mERM (34).
The Mitogen Response
Module
Searching the lactoferrin gene nucleotide
sequence for DNA elements through which
second messenger signals are transduced,
Relative CAT activity
Control DES
1.1±0.4 2.8±1.0
0.9±0.2 33.6±3.9
0.9±0.2 37.3±5.8
Fold of
stimulation
2.5
37.3
41.4
1.0±0.4 108.0±4.3 108.0
1.2±0.5 122.6±15.4 102.3
1.0±0.4 144.2±13.6 144.2
Figure 1. Estrogen effect on lactoferrin gene expres-
sion in the mouse uterus. Twenty-one-day-old female
mice received one injection of DES (20 pg/kg) for 4 and
8 hr or three injections of DES (20 pg/kg/day for 3
days) before sacrifice. Total uterine RNA was prepared
and analyzed by Northern blotting. Mouse lactoferrin
(mLF) cDNA (T267) and histone H2B were used as
probes (9). The sizes ofthe mRNA are indicated.
Figure 2. The imperfect ERE of the mouse lactoferrin gene conferred estrogen responses through a heterologous
promoter. Synthetic oligonucleotides containing the mouse lacoferrin imperfect estrogen response element were
cloned into the reporter gene with simian virus 40 promoter (SV). The various CAT constructs are schematically
presented at the left. The orientation and number of the insert(s) relative to the start site is indicated by the
arrows. Human endometrium carcinoma RL95-2 cells were transiently cotransfected with chimeric CAT reporter
plasmid (5 pg per well), human estrogen response expression vector (HEO, 0.5 pg per well), and ,B-galactosidase
expression vector (pCH1 10, 0.25 pg per well). The transfected cells were treated with 10.8 M DES for 16 hr before
harvest. CAT enzyme activity from the whole-cell extract was measured (30). Relative CAT activity was repre-
sented after normalization for P-galactosidase activity, and the results presented are the averages from at least
four independent experiments performed in duplicate. Control, no treatment.
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we found a DNA sequence (5'GGGCA
ATAGGGTGGGGCCAGCCCGGT
GAGGTCACCCAGCA-3') within 100
bp upstream from the transcription initia-
tion site that is capable of conferring
EGF/TGF-a, cAMP, forskolin, and TPA
action (35). The nucleotide sequence,
5'-GGTGAGGTCACC-3' (mLF-CRE),
which housed the elements resembling
both AP1 and CRE, was responsible for
cAMP and TPA stimulation. Indeed,
mobility shift assays supported the binding
of API and CREB to this sequence.
Cotransfection experiments demonstrated
the involvement of both PKC and PKA
pathways in the activation of the lactofer-
rin gene promoter through the mLF-CRE
element. Mutation experiments showed
that the mLF-CRE plays a dual role in
basal and inducible expression. We were
able to delineate the functional role that
confers EGF/TGF-a and cAMP/TPA-
induced regulation in the mitogen
response unit into two separate regions in
the mouse lactoferrin gene. We named the
region that was responsible for the
EGF/TGF-a stimulation EGFRE
(5'-GGGCAATAGGGTGGGGCC-3').
The in vivo study showed that expres-
sion ofthe lactoferrin gene in mouse uterus
was regulated by EGF (36). It was
proposed that EGF-regulated lactoferrin
expression was via an estrogen receptor
route (36,37). The presence of EGF
response elements in the mouse lactoferrin
gene provided an alternative route of acti-
vation. In addition, the organization ofthe
estrogen response element and EGF
response elements in the mouse gene
(Figure 3) provides an interesting model
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Figure 3. Schematic representation ofthe putative and characterized regulatory elements in the 5'-flanking region
ofthe mouse lactoferrin gene promoter.
system to study the cross communication
between the steroid/thyroid and the
second messenger signaling pathways at
the gene level.
Markerfor Environmental
Chemicals
Many environmental chemicals can mimic
estrogenic effects in animals, but the press-
ing concern is whether these estrogenic
chemicals pose any threat to human health.
Before addressing the risk to human
health, several factors should be consid-
ered. The level, time, and duration of
exposure to these chemicals are critical ele-
ments in establishing any biological
significance. Therefore, a test is needed to
determine these factors; currently in
mammalian systems, there is no established
marker to monitor the effect of estrogenic
chemicals. Based on its sensitivity to estro-
gen, the lactoferrin gene in the mouse
uterus could be a useful marker to measure
the effect ofestrogenic chemicals. It is pos-
sible to use the lactoferrin mRNA and pro-
tein as the biochemical markers to
determine the dose and duration of the
chemicals that mimic the estrogenic effect.
The unique organization of the estrogen
and mitogen response module in the
mouse lactoferrin promoter region serves as
a model system to study the cross commu-
nication between the steroid receptor and
protein kinase pathways.
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